Nebivolol Aurovitas (Nebivolol Hydrochloride)

Nebivolol, the active ingredient in Nebivolol Aurovitas, is a beta blocker presented as an oral tablet for oral use. It treats hypertension and may be used in heart failure management in appropriate patients.

GNH USA supplies Nebivolol Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol is a selective β1‑adrenergic antagonist used in cardiovascular disease management.

Hypertension: reduces systolic and diastolic blood pressure in patients with primary hypertension. Heart failure: improves symptoms and lowers hospitalization rates in chronic heart failure with reduced ejection fraction. Elevated blood pressure in diabetic patients: provides effective control while offering favorable metabolic profile.

Nebivolol may cause a range of adverse reactions.

Common Side Effects: - Headache - Dizziness or light‑headedness - Fatigue or tiredness - Nausea or abdominal discomfort - Bradycardia (slow heart rate) - Peripheral edema

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm or worsening asthma - Allergic reactions including rash or angioedema - Hepatic enzyme elevations - Acute heart failure decompensation

Before initiating therapy, clinicians should consider several safety aspects.

Monitor blood pressure: ensure adequate control without excessive drop. Assess heart rate: watch for bradycardia, especially in patients with conduction disorders. Caution in asthma or chronic obstructive pulmonary disease: β‑blockade may precipitate bronchospasm. Avoid abrupt discontinuation: tapering reduces risk of rebound hypertension. Use with caution in renal or hepatic impairment: dose adjustment may be required. Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nebivolol can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Non‑selective beta blockers (e.g., propranolol) - Calcium‑channel blockers verapamil or diltiazem - Clonidine

Moderate Interactions (Monitor Closely): - ACE inhibitors (e.g., enalapril) - Diuretics (e.g., thiazides) - Antidiabetic agents (e.g., insulin or sulfonylureas)